Rare diseases
Investigational molecules
Locations
Lerodalcibep for Heterozygous Familial Hypercholesterolemia in Children and Adolescents 6 to 17 Years Old
NorwayObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
NorwayIfinatamab deruxtecan in Patients With Advanced Esophageal Squamous Cell Carcinoma
NorwayA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
NorwayPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
NorwayAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
NorwayA study to compare the effectiveness of bupivacaine hydrochloride monohydrate and lidocaine hydrochloride for treating mouth sores in patients with head and neck cancer.
NorwayA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
NorwayA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
NorwayLong‑Term Safety and Efficacy of Infigratinib in Children with Hypochondroplasia
NorwayA study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease
NorwayA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
NorwayTell us about your condition – we search every trial in Europe and connect you with the right site.
